Attorney Robert Hilliard has been practicing law in the state of Texas for over 35 years, gaining national recognition for his work on many high-profile cases. His firm represents clients in mass torts, personal injury, product liability, commercial and business litigation and wrongful death matters.
HOTEL RWANDA HERO KIDNAPPING
In August 2020, Paul Rusesabagina, the man portrayed as a hero in the Academy Award-nominated movie Hotel Rwanda, was taken against his will to Rwanda and charged with terrorism, murder and other crimes. According to the New York Times, Rusesabagina had been asked to travel to Burundi to speak to local churches. In Dubai, he boarded a jet chartered from GainJet, believing he was on a flight to Burundi. Instead, he was taken to the Rwandan capital, Kigali. In partnership with Rusesabagina’s family and international human rights groups, Bob Hilliard agreed to join Mr. Rusesabagina’s legal team. On December 14, 2020, Hilliard and team filed action against GainJet, alleging that Rusesabagina was kidnapped and flown to Rwanda without due process.
On June 7, 2010, Sergio Hernandez Guereca, an unarmed 15-year-old, was playing with his friends near the U.S./Mexico border when he was shot and killed by U.S. Border Patrol agent. Mr. Hilliard, representing the teenager’s family, argued the case before the U.S. Supreme Court on February 21, 2017. Two years later, SCOTUS ruled against Sergio’s family. Mr. Hilliard stated, “In this case, justice doesn’t travel as far as a bullet does. To be left with no remedy, given a lethal and unprovoked shooting, weakens the constitutional foundation of America’s house.”
MERRELL DOW PHARMACEUTICALS
Mr. Hilliard obtained the first multi-million dollar verdict in the Bendectin litigation against Merrell Dow Pharmaceuticals for injuries caused by the morning sickness drug. The jury found in favor of Mr. Hilliard’s client, awarding a verdict of $33.75 million, including $30 million in punitive damages.
In 2013, Mr. Hilliard was the lead trial attorney for 15 patients killed or injured during Bristol-Myers Squibb’s testing of an experimental drug for Hepatitis C. As reported in the Wall Street Journal, he successfully settled the cases for $80 million.